Cell to cell variation helps in studying cells at single as well as multi-levels. The variation at the cell-to-cell level is a natural property of healthy and diseased tissues that stands as a major challenge in drug discovery and development along with prognostics and diagnostics.
Next generation sequencing-based technologies for genomics, transcriptomics, and epigenomics are increasingly focusing on the characterization of an individual cell. The single cell studies allow researchers to expose the unexpected discoveries that are relative to conventional profiling used to assess the bulk population.
Single cell ribonucleic acid (RNA) sequencing helps in studying complex rare populations that can assist in tracking the direction of distinct cell lineages in development and also allows to find out the regulatory relationship between the genes. The following figure illustrates the number of single cell transcriptomics studies in late 2019 and early 2020. The following figure also depicts the percentage of studies on various tissue types in this time frame.
The Single Cell RNA Sequencing Market is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a compound annual growth rate (CAGR) of 17.08% during the forecast period 2021-2031.
The single cell RNA sequencing technology is developed to detect genome, transcriptome and other multi-omics of single cells. It has an advantage of analyzing single cells comprehensively that has created unprecedented opportunities for resolving the cell heterogeneity by expanding gene expression. Further, the commercial availability of next generation sequencing and increased focus on single cell analysis along with the maturing bioinformatics approaches has allowed researchers to incorporate the technology in making discoveries. The dramatic improvement within the technology has allowed it for a better usage in embryonic development, cancer biology, and immunology research.
Get Free Sample - Click Here
Competitive Landscape
By tracking and analyzing the major developments witnessed in the past five years (January 2017- December 2021), the global single cell RNA sequencing market witnessed approximately 23 notable key developments. These included seven product launches, three mergers and acquisitions, nine synergistic developments (partnerships, collaborations, agreements, and business expansion activities), and four business expansion and others. Most of the companies are significantly undertaking product launches and synergistic activities activities to expand their product portfolios and trying to enter untapped markets to increase their global footprint. Therefore, product launches, enhancements, and synergistic activities constitute the dominant contributor’s strategies. The following figure depicts the share of key strategies undertaken by the leading companies in the global single cell RNA sequencing market.
Key Questions Answered in This Report
- What are the key applications of single cell RNA sequencing technology?
- What are the competitor technologies of single cell RNA sequencing technology?
- What are the major drivers, challenges, and opportunities of the global single cell RNA sequencing market?
- What are the key developmental strategies implemented by key players to stand out in this market?
- Who are the leading companies dominating the global single cell RNA sequencing market?
- What is the share of these companies in the global single cell RNA sequencing market?
- What are the regulations pertaining to the global single cell RNA sequencing market? What initiatives are implemented by different government bodies regulating the development and commercialization of single cell RNA sequencing?
- How is each segment of the global single cell RNA sequencing market expected to grow during the forecast period, and what will be the revenue generated by each segment by the end of 2031?
- How will the industry of global single cell RNA sequencing evolve during the forecast period 2021-2031?
- What is the market scenario for the global single cell RNA sequencing market in different regions?
- What are the key trends of different regions in the single cell RNA sequencing market? Which country would contribute to the highest sales of the single cell RNA sequencing market during the forecast period 2021-2031?
- What has been the impact of COVID-19 on the single cell RNA sequencing market?
The Global Single Cell Sequencing Market research study published by Emergen Research is an extensive collection of insightful information about the Single Cell Sequencing industry.
The report covers the Single Cell Sequencing Market segmentation along with a detailed outline of the Single Cell Sequencing market size with regards to volume and valuation.
The report provides comprehensive coverage of the Single Cell Sequencing market scenario for the current period and forecast timeline of 2020-2027The global single-cell sequencing market size was valued at USD 1,136.1 Million in 2019 and is forecasted to reach USD 3,230.6 Million by 2027 at a CAGR of 13.9%.
Single-cell sequencing significant technology for examining rare cells and outlining complex populations.
The rapid growth in market demand is attributed to increasing application in circulating cells, cell differentiation/reprogramming, subpopulation characterization, and genomic variation, among others, in the field of oncology, immunology, prenatal diagnosis, neurobiology, and microbiology.Market Dynamics:The report offers insightful information about the market dynamics of the Single Cell Sequencing market.
It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Single Cell Sequencing market, competitive landscape, factors affecting it, and to predict the growth of the industry.
